Combipres

   
Google
 
Web NewDrugInformation.com

Combipres


Drug - Combipres
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Chlorthalidone; Clonidine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 15MG;0.1MG
The potency of the active ingredient(s), Chlorthalidone; Clonidine Hydrochloride. May repeat for multiple part products.

Applicant - BOEHRINGER INGELHEIM
The firm name holding legal responsibility for Combipres. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017503
The FDA assigned number to Combipres. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Combipres. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Combipres was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Combipres. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Combipres is in. Format is RX, OTC, DISCN.

Applicant Full Name - Boehringer Ingelheim Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Combipres.

Combipres